Biotech Stocks Dive Amid Slower Fed Rate Cuts

  • 📰 ForbesTech
  • ⏱ Reading Time:
  • 36 sec. here
  • 7 min. at publisher
  • 📊 Quality Score:
  • News: 35%
  • Publisher: 59%

BUSINESS أخبار

BIOTECH,FEDERAL RESERVE,INTEREST RATES

The Federal Reserve's decision to slow interest rate cuts has sent biotech stocks plummeting, raising concerns for startups reliant on venture funding.

Biotech stocks experienced a significant decline following the Federal Reserve's announcement of a slower pace for interest rate cuts. The Fed's projection of only two rate cuts in 2025 due to persistent inflation and economic factors contributed to the market downturn. While the Dow, S&P, and Nasdaq also fell, the biotech index XBI and SPBIOS plummeted nearly 5%, and the Nasdaq biotechnology index dropped over 4.2%.

Experts attribute this sensitivity to interest rates due to the sector's continuous funding requirements. This news presents a challenge to biotech startups, as previous rate hikes in 2022 and 2023 led to decreased investments. While recent rate cuts have spurred a slight increase in investment, the current cycle is driven more by fear of missing out (FOMO) than by innovation. To break this cycle, more initial public offerings (IPOs) and mergers and acquisitions (M&A) are needed to provide investors with returns and liquidity, stabilizing the biotech market. However, sustained higher interest rates could impede these activities, making it harder for new startups to thrive and innovate

لقد قمنا بتلخيص هذا الخبر حتى تتمكن من قراءته بسرعة. إذا كنت مهتمًا بالأخبار، يمكنك قراءة النص الكامل هنا. اقرأ أكثر:

 /  🏆 318. in EG
 

شكرًا لك على تعليقك. سيتم نشر تعليقك بعد مراجعته.

مصر أحدث الأخبار, مصر عناوين

Similar News:يمكنك أيضًا قراءة قصص إخبارية مشابهة لهذه التي قمنا بجمعها من مصادر إخبارية أخرى.

4 themes and 4 key biotech stocks for 2025: Jefferies4 themes and 4 key biotech stocks for 2025: Jefferies
مصدر: Investingcom - 🏆 450. / 53 اقرأ أكثر »

Top 2025 Biotech Stocks to Watch Beyond Vaccine MakersStocks Analysis by MarketBeat.com (Nathan Reiff) covering: Eli Lilly and Company, Pfizer Inc, AstraZeneca PLC ADR, Hims Hers Health Inc. Read MarketBeat.com (Nathan Reiff)'s latest article on Investing.com
مصدر: Investingcom - 🏆 450. / 53 اقرأ أكثر »

Three global stocks stocks to own in 2025, according to BarclaysBarclays named 'overweight-rated stocks in which our analysts have high conviction in 2025 and see value in owning on an individual basis.'
مصدر: CNBC - 🏆 12. / 72 اقرأ أكثر »

CNBC Daily Open: U.S. stocks start December chilly; Korea stocks tumble on political chaosDecember may have triggered the thawing of Mariah Carey, but stocks are beginning the month chilly, though unlikely they’ll remain in permafrost this…
مصدر: NBCNewYork - 🏆 270. / 63 اقرأ أكثر »

Wall Street stocks end lower after inflation data, tech stocks push Nasdaq downWall Street stocks end lower after inflation data, tech stocks push Nasdaq down
مصدر: Investingcom - 🏆 450. / 53 اقرأ أكثر »

Asia stocks dip as Nvidia brings little cheer; India slides amid Adani scandalAsia stocks dip as Nvidia brings little cheer; India slides amid Adani scandal
مصدر: Investingcom - 🏆 450. / 53 اقرأ أكثر »